Description & Advantages

• A collection of 1203 compounds reported in cancer research articles, covering multiple cancers.

  An advanced tool for study of oncology mechanism, anti-tumor drug screening and drug structure optimization, or discovery of new drug targets.

  Structurally diverse, partial compounds are FDA-approved or with pharmacokinetics.

  High quality validated by HPLC and NMR.

  All compounds are in stock and continuously updated.

Product Details

• FormulationA collection of 1203 compounds are supplied as pre-dissolved DMSO/Water solutions or powder.
• Container96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode.

• Stability

  12 months	-20°C	in DMSO
  24 months	-80°C	in DMSO

• ShippingBlue ice
• PackagingInert gas